UQCRH

Chr 1AR

ubiquinol-cytochrome c reductase hinge protein

Also known as: MC3DN11, QCR6, UQCR8

The protein is a component of mitochondrial complex III (ubiquinol-cytochrome c oxidoreductase), which transfers electrons from ubiquinol to cytochrome c as part of the electron transport chain that drives ATP synthesis. Mutations cause mitochondrial complex III deficiency with autosomal recessive inheritance. The gene shows low constraint against loss-of-function variants (pLI 0.002, LOEUF 1.347), suggesting tolerance to heterozygous inactivation consistent with the recessive inheritance pattern.

OMIMResearchSummary from RefSeq, OMIM, UniProt
MultiplemechanismARLOEUF 1.351 OMIM phenotype
Clinical SummaryUQCRH
🧬
Gene-Disease Validity (ClinGen)
mitochondrial disease · ARLimited

Limited evidence — not for standalone diagnostic reporting

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
7 unique Pathogenic / Likely Pathogenic· 18 VUS of 35 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.35LOEUF
pLI 0.002
Z-score 0.92
OE 0.64 (0.341.35)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.17Z-score
OE missense 0.94 (0.741.19)
49 obs / 52.4 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.64 (0.341.35)
00.351.4
Missense OE0.94 (0.741.19)
00.61.4
Synonymous OE1.08
01.21.6
LoF obs/exp: 5 / 7.8Missense obs/exp: 49 / 52.4Syn Z: -0.30
DN
0.6647th %ile
GOF
0.74top 25%
LOF
0.1299th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

35 submitted variants in ClinVar

Classification Summary

Pathogenic5
Likely Pathogenic2
VUS18
5
Pathogenic
2
Likely Pathogenic
18
VUS

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
1
0
4
0
5
Likely Pathogenic
0
0
2
0
2
VUS
1
12
5
0
18
Likely Benign
0
0
0
0
0
Benign
0
0
0
0
0
Total21211025

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

UQCRH · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC